nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Quinine—ABCB1—peripheral nervous system neoplasm	0.00357	0.439	CrCbGaD
Quinidine barbiturate—Quinidine—ABCB1—peripheral nervous system neoplasm	0.00314	0.386	CrCbGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.00156	0.12	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—MXI1—peripheral nervous system neoplasm	0.00143	0.11	CbGpPWpGaD
Quinidine barbiturate—Phenobarbital—ABCB1—peripheral nervous system neoplasm	0.00142	0.175	CrCbGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000688	0.0528	CbGpPWpGaD
Quinidine barbiturate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00052	0.000531	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000518	0.000529	CcSEcCtD
Quinidine barbiturate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000516	0.000527	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000526	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000526	CcSEcCtD
Quinidine barbiturate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000514	0.000525	CcSEcCtD
Quinidine barbiturate—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000525	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000512	0.000523	CcSEcCtD
Quinidine barbiturate—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000509	0.00052	CcSEcCtD
Quinidine barbiturate—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.000508	0.0391	CbGpPWpGaD
Quinidine barbiturate—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000519	CcSEcCtD
Quinidine barbiturate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000504	0.000515	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000503	0.000514	CcSEcCtD
Quinidine barbiturate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000503	0.000514	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.000511	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.000511	CcSEcCtD
Quinidine barbiturate—Nausea—Topotecan—peripheral nervous system neoplasm	0.0005	0.000511	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000499	0.00051	CcSEcCtD
Quinidine barbiturate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000498	0.000509	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000497	0.0382	CbGpPWpGaD
Quinidine barbiturate—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000508	CcSEcCtD
Quinidine barbiturate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000496	0.000507	CcSEcCtD
Quinidine barbiturate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000496	0.000507	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000507	CcSEcCtD
Quinidine barbiturate—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000505	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000492	0.000502	CcSEcCtD
Quinidine barbiturate—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.000501	CcSEcCtD
Quinidine barbiturate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00049	0.000501	CcSEcCtD
Quinidine barbiturate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00049	0.0005	CcSEcCtD
Quinidine barbiturate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000487	0.000498	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000484	0.000494	CcSEcCtD
Quinidine barbiturate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000482	0.000493	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000482	0.000493	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000482	0.000493	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000482	0.037	CbGpPWpGaD
Quinidine barbiturate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000492	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000481	0.000491	CcSEcCtD
Quinidine barbiturate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00048	0.00049	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000478	0.000488	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000487	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000487	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000485	CcSEcCtD
Quinidine barbiturate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000482	CcSEcCtD
Quinidine barbiturate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000471	0.000481	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00048	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000469	0.000479	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000467	0.000477	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.000477	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000466	0.000476	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000473	CcSEcCtD
Quinidine barbiturate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000462	0.000472	CcSEcCtD
Quinidine barbiturate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000461	0.000471	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00047	CcSEcCtD
Quinidine barbiturate—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000465	CcSEcCtD
Quinidine barbiturate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.000464	CcSEcCtD
Quinidine barbiturate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000461	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00045	0.000459	CcSEcCtD
Quinidine barbiturate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000448	0.000458	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000454	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000445	0.000454	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000441	0.00045	CcSEcCtD
Quinidine barbiturate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000439	0.000449	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000449	CcSEcCtD
Quinidine barbiturate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000438	0.000447	CcSEcCtD
Quinidine barbiturate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000444	CcSEcCtD
Quinidine barbiturate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000434	0.000444	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000443	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000431	0.00044	CcSEcCtD
Quinidine barbiturate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000431	0.00044	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00043	0.000439	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000437	CcSEcCtD
Quinidine barbiturate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000436	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000427	0.000436	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000427	0.000436	CcSEcCtD
Quinidine barbiturate—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000433	CcSEcCtD
Quinidine barbiturate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000423	0.000432	CcSEcCtD
Quinidine barbiturate—Pain—Etoposide—peripheral nervous system neoplasm	0.000423	0.000432	CcSEcCtD
Quinidine barbiturate—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000431	CcSEcCtD
Quinidine barbiturate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.000428	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000417	0.000427	CcSEcCtD
Quinidine barbiturate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000425	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.00042	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000407	0.000416	CcSEcCtD
Quinidine barbiturate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.000414	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000414	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000404	0.000413	CcSEcCtD
Quinidine barbiturate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000403	0.000412	CcSEcCtD
Quinidine barbiturate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.000411	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000411	CcSEcCtD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.000399	0.0307	CbGpPWpGaD
Quinidine barbiturate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.000408	CcSEcCtD
Quinidine barbiturate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.000408	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000407	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000398	0.000406	CcSEcCtD
Quinidine barbiturate—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000406	CcSEcCtD
Quinidine barbiturate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.000405	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000404	CcSEcCtD
Quinidine barbiturate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000393	0.000401	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000392	0.0004	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.0004	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000391	0.000399	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000391	0.000399	CcSEcCtD
Quinidine barbiturate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000398	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000398	CcSEcCtD
Quinidine barbiturate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000388	0.000396	CcSEcCtD
Quinidine barbiturate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000387	0.000395	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000394	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000393	CcSEcCtD
Quinidine barbiturate—Rash—Vincristine—peripheral nervous system neoplasm	0.000385	0.000393	CcSEcCtD
Quinidine barbiturate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000384	0.000393	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000391	CcSEcCtD
Quinidine barbiturate—Headache—Vincristine—peripheral nervous system neoplasm	0.000382	0.000391	CcSEcCtD
Quinidine barbiturate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.000384	CcSEcCtD
Quinidine barbiturate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000384	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000383	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000369	0.000377	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000377	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000375	CcSEcCtD
Quinidine barbiturate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000372	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000364	0.000372	CcSEcCtD
Quinidine barbiturate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000371	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000371	CcSEcCtD
Quinidine barbiturate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000362	0.00037	CcSEcCtD
Quinidine barbiturate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000362	0.00037	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000362	0.00037	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000369	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000369	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000364	CcSEcCtD
Quinidine barbiturate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000355	0.000362	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000361	CcSEcCtD
Quinidine barbiturate—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000352	0.0271	CbGpPWpGaD
Quinidine barbiturate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000352	0.00036	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000359	CcSEcCtD
Quinidine barbiturate—Chills—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000357	CcSEcCtD
Quinidine barbiturate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00035	0.000357	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000355	CcSEcCtD
Quinidine barbiturate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000343	0.00035	CcSEcCtD
Quinidine barbiturate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000349	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000349	CcSEcCtD
Quinidine barbiturate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00034	0.000348	CcSEcCtD
Quinidine barbiturate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00034	0.000347	CcSEcCtD
Quinidine barbiturate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000347	CcSEcCtD
Quinidine barbiturate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000347	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000338	0.000346	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000345	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000344	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000342	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000342	CcSEcCtD
Quinidine barbiturate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00034	CcSEcCtD
Quinidine barbiturate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000337	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000328	0.0252	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000327	0.000334	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000333	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000332	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000331	CcSEcCtD
Quinidine barbiturate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00032	0.000327	CcSEcCtD
Quinidine barbiturate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000327	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000323	CcSEcCtD
Quinidine barbiturate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000314	0.000321	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000321	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000321	CcSEcCtD
Quinidine barbiturate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000319	CcSEcCtD
Quinidine barbiturate—Rash—Etoposide—peripheral nervous system neoplasm	0.000312	0.000318	CcSEcCtD
Quinidine barbiturate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000311	0.000318	CcSEcCtD
Quinidine barbiturate—Headache—Etoposide—peripheral nervous system neoplasm	0.00031	0.000316	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000315	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000312	CcSEcCtD
Quinidine barbiturate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000312	CcSEcCtD
Quinidine barbiturate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000311	CcSEcCtD
Quinidine barbiturate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00031	CcSEcCtD
Quinidine barbiturate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000306	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000305	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000302	CcSEcCtD
Quinidine barbiturate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000301	CcSEcCtD
Quinidine barbiturate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000294	0.0003	CcSEcCtD
Quinidine barbiturate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000295	CcSEcCtD
Quinidine barbiturate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000295	CcSEcCtD
Quinidine barbiturate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000295	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000295	CcSEcCtD
Quinidine barbiturate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000294	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000293	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000288	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000288	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000282	0.0216	CbGpPWpGaD
Quinidine barbiturate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000287	CcSEcCtD
Quinidine barbiturate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000285	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000284	CcSEcCtD
Quinidine barbiturate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000283	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000282	CcSEcCtD
Quinidine barbiturate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000278	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000278	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000278	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000277	CcSEcCtD
Quinidine barbiturate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000276	CcSEcCtD
Quinidine barbiturate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000275	CcSEcCtD
Quinidine barbiturate—GABRA2—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000269	0.0206	CbGpPWpGaD
Quinidine barbiturate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000274	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000273	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000273	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000273	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000272	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000271	CcSEcCtD
Quinidine barbiturate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00027	CcSEcCtD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—PTPN11—peripheral nervous system neoplasm	0.000264	0.0203	CbGpPWpGaD
Quinidine barbiturate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000264	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000264	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000257	0.0197	CbGpPWpGaD
Quinidine barbiturate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000262	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000258	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000258	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000257	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000256	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000256	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000254	CcSEcCtD
Quinidine barbiturate—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000248	0.0191	CbGpPWpGaD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000253	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000252	CcSEcCtD
Quinidine barbiturate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000252	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00025	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000246	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000245	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000244	CcSEcCtD
Quinidine barbiturate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000242	CcSEcCtD
Quinidine barbiturate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000242	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000239	CcSEcCtD
Quinidine barbiturate—GABRA1—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000229	0.0176	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000234	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000233	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000233	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000231	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000228	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000226	CcSEcCtD
Quinidine barbiturate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000225	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000224	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000224	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000224	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000224	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000216	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000214	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000209	CcSEcCtD
Quinidine barbiturate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000208	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000207	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000207	CcSEcCtD
Quinidine barbiturate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000203	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.000197	0.0151	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000196	0.0002	CcSEcCtD
Quinidine barbiturate—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000192	0.0148	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000194	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000193	CcSEcCtD
Quinidine barbiturate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000188	CcSEcCtD
Quinidine barbiturate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000187	CcSEcCtD
Quinidine barbiturate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000185	CcSEcCtD
Quinidine barbiturate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00018	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000179	CcSEcCtD
Quinidine barbiturate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000178	CcSEcCtD
Quinidine barbiturate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000178	CcSEcCtD
Quinidine barbiturate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000177	CcSEcCtD
Quinidine barbiturate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000173	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000168	0.0129	CbGpPWpGaD
Quinidine barbiturate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000168	CcSEcCtD
Quinidine barbiturate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000167	CcSEcCtD
Quinidine barbiturate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000165	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000165	CcSEcCtD
Quinidine barbiturate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000164	CcSEcCtD
Quinidine barbiturate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000156	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000143	0.011	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000139	0.0107	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000137	0.0105	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000137	0.0105	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000131	0.0101	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000127	0.00977	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000126	0.00964	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000125	0.0096	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000107	0.00821	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000105	0.00804	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000104	0.00796	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—BCHE—peripheral nervous system neoplasm	9.62e-05	0.00739	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	9.43e-05	0.00725	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	9.38e-05	0.00721	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	8.84e-05	0.00679	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	8.71e-05	0.00669	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	8.64e-05	0.00664	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BCHE—peripheral nervous system neoplasm	8.49e-05	0.00652	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	8.05e-05	0.00619	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	7.54e-05	0.00579	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	7.39e-05	0.00567	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	7.04e-05	0.00541	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BCHE—peripheral nervous system neoplasm	6.77e-05	0.0052	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	6.77e-05	0.0052	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	6.7e-05	0.00514	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—HRAS—peripheral nervous system neoplasm	6.61e-05	0.00507	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.56e-05	0.00504	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	6.25e-05	0.0048	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	6.13e-05	0.00471	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	5.88e-05	0.00452	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BCHE—peripheral nervous system neoplasm	5.77e-05	0.00443	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	5.73e-05	0.0044	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.6e-05	0.0043	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	5.51e-05	0.00423	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.34e-05	0.0041	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.18e-05	0.00397	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	4.55e-05	0.0035	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	4.48e-05	0.00344	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.15e-05	0.00319	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	3.98e-05	0.00306	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	3.92e-05	0.00301	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	3.83e-05	0.00294	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.62e-05	0.00278	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	3.52e-05	0.0027	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.47e-05	0.00267	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.47e-05	0.00266	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	3.38e-05	0.0026	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.28e-05	0.00252	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	3.2e-05	0.00246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.15e-05	0.00242	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.02e-05	0.00232	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.96e-05	0.00227	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.96e-05	0.00227	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.95e-05	0.00226	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.79e-05	0.00215	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.76e-05	0.00212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.76e-05	0.00212	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.75e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.75e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.74e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.63e-05	0.00202	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.49e-05	0.00192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.41e-05	0.00185	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	2.39e-05	0.00184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.39e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.38e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.35e-05	0.00181	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.34e-05	0.0018	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.34e-05	0.0018	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.26e-05	0.00173	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.2e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.07e-05	0.00159	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.99e-05	0.00153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.86e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.86e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	1.82e-05	0.0014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.78e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.78e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.77e-05	0.00136	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.59e-05	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.56e-05	0.0012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.41e-05	0.00109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.41e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.36e-05	0.00105	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.35e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.34e-05	0.00103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.3e-05	0.001	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.3e-05	0.000999	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000989	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.24e-05	0.000952	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.24e-05	0.00095	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.15e-05	0.000883	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.77e-06	0.00075	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.59e-06	0.00066	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.35e-06	0.000642	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	8.13e-06	0.000625	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.96e-06	0.000612	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.31e-06	0.000561	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	6.87e-06	0.000528	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.56e-06	0.000504	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	6.46e-06	0.000496	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	5.28e-06	0.000405	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.18e-06	0.000398	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.17e-06	0.000397	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.08e-06	0.00039	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.01e-06	0.000308	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.78e-06	0.00029	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.68e-06	0.000282	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.64e-06	0.00028	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.34e-06	0.000256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.05e-06	0.000234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.84e-06	0.000218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.34e-06	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.23e-06	0.000172	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.97e-06	0.000151	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.42e-06	0.000109	CbGpPWpGaD
